Caryn Lerman: The KSOM/Norris Center for Cancer Cellular Immunotherapy Research Helps Facilitate Promising Cancer Cellular Immunotherapies
Caryn Lerman, Director of Norris Comprehensive Cancer Center at Keck Medicine of USC, shared a post on LinkedIn:
“Cellular immunotherapies are a promising therapy for the treatment of cancer.
These therapies have already changed clinical practice for hematologic malignancies like leukemia and lymphoma and are poised to do the same for solid cancers like prostate, pancreas, ovarian, and colorectal.
The KSOM/Norris Center for Cancer Cellular Immunotherapy Research, led by founding director Dr. Saul Priceman, PhD, was created to help facilitate promising cancer cellular immunotherapies to patients. Its mission is to provide a nucleus for novel cellular immunotherapy ideas and advance translational research poised for clinical development.
Learn more in the video.”
Proceed to the video attached to the post.
More posts featuring Caryn Lerman
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023